The suit, which was brought against Valeant and two leaders of the now-defunct Philidor, emphasized price hikes on Valeant drugs, spelling out many of them, such as an increase in the price of the diabetes drug Glumetza by more than 800%. The suit claims the company’s relationship with specialty mail-order pharmacy Philidor Rx Services was illegal and allowed Valeant to overcharge and wrongly charge for prescription drugs, in violation of the Racketeer Influenced and Corrupt Organizations Act.
“Valeant was able to implement many of these price hikes because it was simultaneously steering patients and physicians away from generic equivalents and toward Valeant-branded drugs through its secretly controlled network of pharmacies led by Philidor,” the lawsuit states.
Valeant Pharmaceutical has allegedly reaped around $500 million through its secretive scheme via Philidor, Valeant’s captive pharmacy hub.
*****A VITAL NOTE FROM THE PIRL TEAM: As we report on any medical product/medication case - NEVER STOP OR ALTER A MEDICAL PROGRAM OR COURSE OF MEDICATION WITHOUT CONSULTING YOUR(S) OR A PHYSICIAN.*****